Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota.

Frontiers in endocrinology - 1 Jan 2021

Wang Xuejiao, Xu Ting, Liu Rui, Wu Guojun, Gu Liping, Zhang Yahui, Zhang Feng, Fu Huaqing, Ling Yunxia, Wei Xiaohui, Luo Yunchen, Shen Jian, Zhao Liping, Peng Yongde, Zhang Chenhong, Ding Xiaoying

Abstract excerpt

Objective: Gut microbial dysbiosis is associated with high heterogeneity of polycystic ovary syndrome (PCOS); however, studies about gut microbiota targeted clinical intervention in PCOS are limited. Our study aimed to evaluate the effects of high-fiber diet or combined with acarbose on the clinical phenotypes of PCOS, focusing on the possible influence of gut microbiota in this process. Methods: Twenty-five...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dysbiosis
Share to Gastrointestinal Microbiome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal motility and disorders

Share to Gut microbiota and health

Share to Ovarian function and disorders

Share to Phenotype

Share to Polycystic Ovary Syndrome

Source

Open in PubMed Open full text

Identifiers

PMID: 35185786
DOI: 10.3389/fendo.2021.806331
PMCID: PMC8847200

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota.PMID 35185786Read ↗

Comprehensive Analysis of Gut Microbiota Alteration in the Patients and Animal Models with Polycystic Ovary SyndromeSemantic proximity Read ↗

Alteration of gut microbiota in polycystic ovary syndrome patients and the correlated clinical parameters: a cross-sectional analysis study from Chinese womenSemantic proximity Read ↗

Polycystic Ovary Syndrome: Etiology, Current Management, and Future TherapeuticsSemantic proximity Read ↗

Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applicationsSemantic proximity Read ↗

Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndromeSemantic proximity Read ↗

Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemiaSemantic proximity Read ↗

16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary SyndromeSemantic proximity Read ↗

The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A ReviewSemantic proximity Read ↗

Polycystic Ovary Syndrome and Gut Microbiota: Phenotype MattersSemantic proximity Read ↗

Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype.Semantic proximity Read ↗

BMI-stratified phenotypes of polycystic ovary syndrome: advances in gut microbiota research and personalized management strategies.Semantic proximity Read ↗

Probiotic Bifidobacterium lactis V9 regulates the intestinal microbiome in patients with polycystic ovary syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.